Boston Globe reporter Robert Weisman writes about how a new startup is using technology developed in part by Prof. Robert Langer to try to reverse hearing loss. The company is applying Langer’s research to “regenerate sensory hair cells in the inner ear to treat the noise-induced hearing loss that affects an estimated 48 million Americans and millions more worldwide.”
STAT reporter Kate Sheridan spotlights the 2017 Koch Institute Image Awards, which aim to recognize visual images produced through life sciences and biomedical research. Sheridan notes that the competition shows “everyone how beautiful biology can be — no microscope required.”
Popular Science reporter Rob Verger writes that MIT researchers have identified a way to prevent the body from developing scar tissue around medical implants. The “discovery involves using drugs to affect the behavior of a type of immune system cell called a macrophage in a way that prevents the buildup of scar tissue.”
MIT researchers have developed a cost-effective, cell analysis method using graphene sheets, reports Brooks Hays for UPI. The new technique could allow “simple sheets of graphene oxide to function as a diagnostics device for medical and biological tests,” Hays explains.
Postdoctoral associate Phillip Nadeau speaks with CBC reporter Nora Young about a new ingestible electronic device developed by MIT researchers that could potentially be used to transmit patient data or deliver medications. Young explains that the new device “doesn't require a battery, because it's able to create an electrical current from the acid in your stomach.”
Research affiliate Giovanni Traverso speaks with Ira Flatow of Science Friday about a new ingestible device powered by stomach acid. “When you start thinking about keeping a system inside of the body for a long time,” Traverso explains, “powering that system becomes a challenge, and that’s exactly what we tried to aim to address here with this study.”
MIT researchers have developed an ingestible device that is powered by stomach acid and can deliver drugs for up to one week, reports Brooks Hays of UPI. "Our work helps pave the way toward a new era of pill-sized electronics, which can operate over the course of weeks or even months in the gastrointestinal tract,” says Giovanni Traverso, a research affiliate at the Koch Institute.
MIT researchers have developed a pill that uses stomach acid to run sensors in the body and can deliver drugs over a long period of time, writes Hallie Smith of Boston Magazine. By attaching zinc and copper electrodes to the exterior of the pill it “reacts with stomach acid to create electricity,” explains Smith.
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Tyler Jacks, director of the Koch Institute, speaks with Meghna Chakrabarti of WBUR’s Radio Boston about cancer research in Boston. Jacks says the large number of researchers in the area “gives us a distinctive advantage,” as it provides researchers the opportunity to interact and collaborate with various institutions.
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
A new drug delivery system developed by MIT researchers may help eradicate malaria and could boost medication adherence, writes Rachel Zimmerman for WBUR’s Bostonomix. "People don't take their medicines and this might be a way, someday, for Alzheimer's patients to have much better treatments and people with mental health diseases to have much better treatments," says Prof. Langer.
MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”
Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”
MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”